Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon - Sufenta forte, Injektionslösung Swissmedic Registration 52413 Sequence 02 Product name Sufenta forte Description Injektionslösung ATC-Classification N01AH03 ATC-Description Sufentanil Introduction of Sequence 27.06.1994
Composition sufentanilum 50 µg ut sufentanili citras, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml corresp., natrium 3.54 mg. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Sufentanil 50 µg/ml
Inactive agents Acidum Hydrochloridum Sodium Chloride Sodium Hydroxide
Package number Package Size EFP CP Category SL Out of trade (MedRef) 044 5 1 ampoule(s) à 1 ml PR PR A+ Yes 052 5 1 ampoule(s) à 5 ml PR PR A+ Yes
